2012 BMT ICU Utilization Project Update  by Jenkins, Trisha
Abstracts / Biol Blood Marrow Transplant 19 (2013) S342eS354 S353Purpose: Deﬁne the structure and standard of the NC/CTN
role, in line with Hem/HCT department and nursing leader-
ship goals. Improve patient outcomes through evidence
based practice and collaborationwith multidisciplinary team
throughout the decision making process. Maintain autono-
mous professional nursing role while providing empower-
ment and role satisfaction.
Intervention: Shared governance education was provided
to staff followed by an electronic survey to gauge interest in
creating and participating in a unit based council. A subset
of volunteers was selected to serve on the newly created
UBC. Through an evidence based approach, a charter
was established. Members serve as representatives of our
NC/CTN staff within which members rotate leadership
positions.
Evaluation/Discussion: Once the charter was developed and
approved, per quorum, work commenced on the initiatives:
1) Ownership of ‘the patient and family transplant education
class’ was returned to the NC staff. This opportunity for
change resulted from an issue identiﬁed in a “management
of daily improvement” (MDI) huddle. 2) The material taught
was reviewed and updated to current practice, utilizing input
from a non-UBC sub-committee. To date, we have seen an
overall increase in attendance and have established
measurable units. It is too early to determine degree of
success, however this initiative will help better serve our
patients, improve outcomes and allow us to address future
concerns with measurable targets. 3) A staff satisfaction
survey was developed, implemented, analyzed and pre-
sented. Ideas to improve overall satisfaction are currently
underway. 4) Creation of a standard orientation work ﬂow
process, role speciﬁc checklists and central orientation
binder for reference of the deﬁned standards, is work in
progress. Each group in the NC/CTN ofﬁce has their own
orientation model without a universal process between
groups. To address this need, a structured framework was
applied to the existing process in attempt to streamline the
comprehensive orientation process and centralize references
for new employees joining the group.
Future and on-going projects include: 1) Standardize
documentation; 2) Collect professional articles that repre-
sent current ‘best’ evidence based practices for imple-
mentation; 3) Create reward and recognition programwithin
NC/CTN group; and 4) Update annual review evaluation
forms.489
2012 BMT ICU Utilization Project Update
Trisha Jenkins. BMT Nursing, Stanford Hospital, Stanford, CA
Signiﬁcance & Background: Resource utilization in health-
care continues to be a top priority. The rising cost of
healthcare and limited resources, including ICU beds, makes
appropriate utilization of the ICU a critical issue.10 years ago,
our BMT Program developed and began utilizing ICU
admission criteria. We have monitored ICU utilization by
collecting data on whether patients met criteria for ICU
admission, the reason for transfer, the length stay and
outcomes. Historically, BMT patients are high acuity and now
older patients with co-morbidities are candidates for trans-
plant. Appropriate ICU utilization is an important goal of our
program.
Purpose: The 10 years of data allows us to evaluate proba-
bilities of survival following ICU with the goal of appropriate
ICU utilization.Interventions: We have developed and continue to revise
ICU admission criteria based on ongoing review of the ICU
data. An understanding of outcomes following ICU is used by
the medical team to counsel patients and families facilitating
informed decisions about their care. To improve the care of
patients in the ICU, the BMT and ICU teams round together
daily including a discussion of goals of care and family
meetings every 2-3 days.
Evaluation: Ongoing evaluation determines if ICU admission
criteria was met, reasons for transfer, length of stay and
outcomes. Most of the patients transferred to the ICU meet
our established criteria. We have noted trends for patients
transferred to the ICU more than once have very poor
outcomes. Additionally, the length of ICU stay predicts for
poor outcomes.
Discussion: Ongoing evaluation of our ICU utilization data
and reviews of the literature provide the BMT team with
information that can be used to counsel patients and families
on the probabilities of survival. This information allows for
patients and families to make informed choices regarding
their care and facilitates appropriate ICU utilization.490
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Background: Reducing the time a patient is present in the
apheresis facility for autologous collection can help trans-
plant centers better utilize staff. Waiting for CD34+ cell count
results can delay start of apheresis for an hour or more. An
alternative test for prediction of stem cell mobilization using
HPC count to provide a quickly resulted (<5 minutes) proxy
for CD34+ results was explored. The HPC parameter is
measured using the Sysmex XE analyzer and is a less mature
cell with a 0.7 correlation with CD34+ cell count. We
implemented this test in combination with CD34+ testing to
identify patients who could start apheresis without waiting
for the CD34+ results. The goal was to reduce patient wait
time and deliver the product to the processing lab earlier,
with better utilization of technicians.
Methods: Using previously collected data, our center
decided to collect immediately any autologous patient not
mobilized with AMD who had an HPC value of over 30. The
cutoff was set high to minimize false positives, patients who
were run who ultimately had low counts. Based on the
guideline we established, we allocated patients to two
subsets: move to apheresis without waiting for CD34+
results or hold for CD34+ results. Patients who were held
pending CD34+ results were subsequently assessed accord-
ing to Institute standards. We collected baseline and post-
implementation data to assess howmuch time patients were
spending in apheresis and the time that elapsed before
delivery to the processing lab pre- and post-implementation.
Results: Of the eligible patients, 62% could begin apheresis
upon HPC resulting and 38% were categorized as needing to
wait for CD34+ results. In the ﬁrst 3 months post-imple-
mentation, patients who initiated collection based on the
HPC parameter were found to begin collecting 40 minutes
earlier than historic averages, and over an hour earlier than
